MoonLake Immunotherapeutics Class A Ordinary Shares
XNAS:MLTX
16.07
$16.09 - 25.00
$16.06 - 468.00
$15.97
$16.86
$16.71
$16.71
62.75
5.95
714138
5862137
63132328.48
Chart
TendieTensor AI Analysis
Company
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Fundamentals
100
-5.020000
3.684600
100
BBG00XQZQTS9
BBG00XQZQVP7
63.50M
70.85M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own MLTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.